Schroeder A, Loth M, Luo C, Yao S, Yan H, Zhang D
bioRxiv. 2025; .
PMID: 40060412
PMC: 11888418.
DOI: 10.1101/2025.02.25.640190.
Blaylock R
Surg Neurol Int. 2025; 16:26.
PMID: 39926461
PMC: 11799683.
DOI: 10.25259/SNI_1114_2024.
Orian J
J Neuroimmune Pharmacol. 2025; 20(1):14.
PMID: 39904925
PMC: 11794395.
DOI: 10.1007/s11481-025-10182-w.
Ziccardi S, Crescenzo F, Guandalini M, Caliskan G, Martinelli L, Tamanti A
Brain Commun. 2024; 6(6):fcae355.
PMID: 39494361
PMC: 11528517.
DOI: 10.1093/braincomms/fcae355.
Gadani S, Singh S, Kim S, Hu J, Smith M, Calabresi P
Elife. 2024; 12.
PMID: 39475792
PMC: 11524578.
DOI: 10.7554/eLife.88414.
The use of 7T MRI in multiple sclerosis: review and consensus statement from the North American Imaging in Multiple Sclerosis Cooperative.
Harrison D, Sati P, Klawiter E, Narayanan S, Bagnato F, Beck E
Brain Commun. 2024; 6(5):fcae359.
PMID: 39445084
PMC: 11497623.
DOI: 10.1093/braincomms/fcae359.
Impairment of spinal CSF flow precedes immune cell infiltration in an active EAE model.
Xin L, Madarasz A, Ivan D, Weber F, Aleandri S, Luciani P
J Neuroinflammation. 2024; 21(1):272.
PMID: 39444001
PMC: 11520187.
DOI: 10.1186/s12974-024-03247-9.
Cortical CD200-CD200R and CD47-SIRPα expression is associated with multiple sclerosis pathology.
van den Bosch A, Wever D, Schonewille P, Schuller S, Smolders J, Hamann J
Brain Commun. 2024; 6(4):fcae264.
PMID: 39175944
PMC: 11339711.
DOI: 10.1093/braincomms/fcae264.
Low intensity repetitive transcranial magnetic stimulation enhances remyelination by newborn and surviving oligodendrocytes in the cuprizone model of toxic demyelination.
Nguyen P, Makowiecki K, Lewis T, Fortune A, Clutterbuck M, Reale L
Cell Mol Life Sci. 2024; 81(1):346.
PMID: 39134808
PMC: 11335270.
DOI: 10.1007/s00018-024-05391-0.
New Imaging Markers in Multiple Sclerosis and Related Disorders: Smoldering Inflammation and the Central Vein Sign.
Hemond C, Gaitan M, Absinta M, Reich D
Neuroimaging Clin N Am. 2024; 34(3):359-373.
PMID: 38942521
PMC: 11213979.
DOI: 10.1016/j.nic.2024.03.004.
Association of Cortical Lesions With Regional Glutamate, GABA, -Acetylaspartate, and Myoinositol Levels in Patients With Multiple Sclerosis.
Madsen M, Povazan M, Wiggermann V, Lundell H, Blinkenberg M, Romme Christensen J
Neurology. 2024; 103(1):e209543.
PMID: 38870443
PMC: 11244746.
DOI: 10.1212/WNL.0000000000209543.
Contribution of new and chronic cortical lesions to disability accrual in multiple sclerosis.
Beck E, Mullins W, Silva J, Filippini S, Parvathaneni P, Maranzano J
Brain Commun. 2024; 6(3):fcae158.
PMID: 38818331
PMC: 11137753.
DOI: 10.1093/braincomms/fcae158.
Efficacy of intrathecal mesenchymal stem cell-neural progenitor therapy in progressive MS: results from a phase II, randomized, placebo-controlled clinical trial.
Harris V, Stark J, Williams A, Roche M, Malin M, Kumar A
Stem Cell Res Ther. 2024; 15(1):151.
PMID: 38783390
PMC: 11119709.
DOI: 10.1186/s13287-024-03765-6.
Long-term in vivo three-photon imaging reveals region-specific differences in healthy and regenerative oligodendrogenesis.
Thornton M, Futia G, Stockton M, Budoff S, Ramirez A, Ozbay B
Nat Neurosci. 2024; 27(5):846-861.
PMID: 38539013
PMC: 11104262.
DOI: 10.1038/s41593-024-01613-7.
The prevalence and topography of spinal cord demyelination in multiple sclerosis: a retrospective study.
Waldman A, Catania C, Pisa M, Jenkinson M, Lenardo M, DeLuca G
Acta Neuropathol. 2024; 147(1):51.
PMID: 38460050
PMC: 10924711.
DOI: 10.1007/s00401-024-02700-6.
The diagnosis of multiple sclerosis: what has changed in diagnostic criteria?.
Jankowska A, Chwojnicki K, Szurowska E
Pol J Radiol. 2024; 88:e574-e581.
PMID: 38362016
PMC: 10867947.
DOI: 10.5114/pjr.2023.133677.
Transcript Profiles of Microglia/Macrophage Cells at the Borders of Chronic Active and Subpial Gray Matter Lesions in Multiple Sclerosis.
Chomyk A, Kucinski R, Kim J, Christie E, Cyncynatus K, Gossman Z
Ann Neurol. 2024; 95(5):907-916.
PMID: 38345145
PMC: 11060930.
DOI: 10.1002/ana.26877.
Ocrelizumab reduces cortical and deep grey matter loss compared to the S1P-receptor modulator in multiple sclerosis.
Bajrami A, Tamanti A, Peloso A, Ziccardi S, Guandalini M, Calderone M
J Neurol. 2024; 271(5):2149-2158.
PMID: 38289534
PMC: 11055717.
DOI: 10.1007/s00415-023-12179-y.
White matter paramagnetic rim and non-rim lesions share a periventricular gradient in multiple sclerosis: A 7-T imaging study.
Miscioscia A, Treaba C, Barletta V, Herranz E, Sloane J, Barbuti E
Mult Scler. 2024; 30(2):166-176.
PMID: 38279672
PMC: 10922980.
DOI: 10.1177/13524585231224681.
An Association of Chitinase-3 Like-Protein-1 With Neuronal Deterioration in Multiple Sclerosis.
Ahmad I, Wergeland S, Oveland E, Bo L
ASN Neuro. 2023; 15:17590914231198980.
PMID: 38062768
PMC: 10710113.
DOI: 10.1177/17590914231198980.